Onco-Innovations Advances AI and Quantum Drug Discovery with Kuano Collaboration to Accelerate PNKP Inhibitor Technology Development

Core Insights - Onco-Innovations Limited is initiating a pilot project with Kuano Ltd to accelerate the development of its PNKP Inhibitor Technology, also known as A83B4C63 [1] Company Overview - Onco-Innovations Limited is publicly traded on multiple exchanges, including CBOE CA:ONCO, OTCQB:ONNVF, and Frankfurt:W1H [1] Project Details - The pilot project aims to enhance the development timeline and effectiveness of Onco's PNKP Inhibitor Technology [1]